Skip to content

Curative effect observation on the patients' mental, behavioral and cognitive functions with treatment of delayed encephalopathy caused by acute carbon monoxide poisoning with DL-3 n-butylphthalide and dexamethasone combined with hyperbaric oxygen

Curative effect observation on the patients' mental, behavioral and cognitive functions with treatment of delayed encephalopathy caused by acute carbon monoxide poisoning with DL-3 n-butylphthalide and dexamethasone combined with hyperbaric oxygen

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030608
Enrollment
Unknown
Registered
2020-03-08
Start date
2020-03-15
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed encephalopathy after acute carbon monoxide poisoning

Interventions

experimental group:NBP and DXM combined with HBO
control group:DXM and HBO

Sponsors

Heze Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients meeting the following criteria were included: 1. patients with a history of CO exposure; 2. Patients with a Mini-Mental State Examination (MMSE) score of no more than 24; 3. Patients with clinical symptoms of DEACMP occurring after 2-60 days of a latent period without any clinical manifestation of acute CO poisoning; 4. Patients with neuroimaging evidence of demyelination lesions of bilateral cerebral white matter in brain MRI; 5. Patients who provid written or oral informed consent and complet all of the treatment programme and a follow-up plan.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: 1. With history of severe allergy to NBP or DXM; 2. With history of anxiety,depression and other mental illness; 3. Patients who had chronic hepatic or renal insufficiency; 4. With intellectual impairment; 5. With stroke; 6. With systemic infection or severe local infection; 7. With coagulation disorders; 8. With HIV,hepatitis B virus (HBV)/C virus (HCV); 9. With syphilis; 10. With genetic disorders or pregnancy.

Design outcomes

Primary

MeasureTime frame
the Mini-Mental State Examination;the Montreal cognitive assessment;the Barthel index of activities of daily living;the Hamilton Anxiety Scale;Hamilton Depression Scale;

Countries

China

Contacts

Public ContactChen Yankun

Heze Municipal Hospital

kundan@126.com+86 18853054120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026